Sarthak Meditech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 2.50 M
- Revenue Growth -58.85%
- Profit Growth -76.28%
- Ebitda 113.06%
- Net Worth 1.22%
- Total Assets 40.76%
About Sarthak Meditech
Sarthak Meditech Private Limited (SMPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 October 2012 and has a history of 12 years and four months. Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M.
Ajay Rajvanshi and Narayan Rajvanshi serve as directors at the Company.
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232RJ2012PTC040311
- Company No.
040311
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Oct 2012
- Date of AGM
30 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Sarthak Meditech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Rajvanshi  | Director | 05-Oct-2012 | Current |
| Narayan Rajvanshi | Director | 05-Oct-2012 | Current |
Financial Performance of Sarthak Meditech.
Sarthak Meditech Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 58.85% decrease. The company also saw a substantial fall in profitability, with a 76.28% decrease in profit. The company's net worth moved up by a moderate rise of 1.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sarthak Meditech?
In 2018, Sarthak Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.50 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Maharashtra : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Dec 2013 | Bank Of Maharashtra | ₹2.50 M | Open |
How Many Employees Work at Sarthak Meditech?
Unlock and access historical data on people associated with Sarthak Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarthak Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarthak Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
